Vascular News and Research

RSS
New study finds height as possible risk factor for developing varicose veins

New study finds height as possible risk factor for developing varicose veins

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization

Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization

Study: Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation

Study: Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation

Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch

Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Immediate compression therapy could cut risk of complications after deep-vein thrombosis

Immediate compression therapy could cut risk of complications after deep-vein thrombosis

Chaos and agitation: Helping a patient survive a hurricane

Chaos and agitation: Helping a patient survive a hurricane

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Celltrion and Emory University sign 'Incubation' agreement to develop new drug candidates for atherosclerosis

Study shows how cellular waste disposal processes also promote inflammation

Study shows how cellular waste disposal processes also promote inflammation

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Study gives new insights into how cells leverage GPCRs to control inflammation

Study gives new insights into how cells leverage GPCRs to control inflammation

KAIST researchers develop heart-targeting drug delivery technology using tannin acid

KAIST researchers develop heart-targeting drug delivery technology using tannin acid

NIH funds CWRU to investigate new imaging approach for diagnosing peripheral arterial disease

NIH funds CWRU to investigate new imaging approach for diagnosing peripheral arterial disease

Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain

Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Daily low-dose aspirin does not prolong healthy life in older people, study finds

Daily low-dose aspirin does not prolong healthy life in older people, study finds

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

Study: aPKC inhibitors may provide new therapeutic option for blinding eye diseases

FDA awards grants to enhance development of medical devices for pediatric patients

FDA awards grants to enhance development of medical devices for pediatric patients

Research shows novel approach for treatment of myocardial infarction

Research shows novel approach for treatment of myocardial infarction

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.